Target antigens for T-cell engager therapies in ALL and AML

Target antigens for T-cell engager therapies in ALL and AML

VJHemOnc

1 year
691 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
T-cell engaging antibodies are more straightforward to deisgn and use in acute lymphoblastic leukemia (ALL) compared with acute myeloid leukemia (AML), and have thus had more success. Here, Marion Subklewe, MD, of LMU-University Hospital Munich, Munich, Germany, explains the reasons for this difference and how we can improve response rates to this type of therapy in AML. This video was recorded at the 1st International Workshop on Acute Leukemias (iwAL), held in St. Pete Beach, FL.
Up Next Autoplay
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
0 Views
Cancer-News 12 minutes
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
0 Views
Cancer-News 25 minutes
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
0 Views
Cancer-News 47 minutes
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
1 Views
Cancer-News 1 hour
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
2 Views
Cancer-News 2 hours
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
2 Views
Cancer-News 2 hours
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
1 Views
Cancer-News 3 hours
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
3 Views
Cancer-News 3 hours
Personalized Algorithms: How is this different?
Personalized Algorithms: How is this different?
Category: Immunotherapy
4 Views
Cancer-News 23 hours
Algorithm Personalizing Best Targets for Immunotherapy
Algorithm Personalizing Best Targets for Immunotherapy
Category: Immunotherapy
3 Views
Cancer-News 1 day